Vice Provost and Dean of Research
Showing 111-120 of 1,742 Results
-
Miles Berger
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)
BioI am a neuroanesthesiologist and translational human neuroscientist. Clinically, I care for patients undergoing brain and spine surgery, and have an interest in optimizing anesthesia care (and postoperative cognitive outcomes) for older surgical patients.
My research team studies mechanisms of perioperative neurocognitive disorders (such as delirium) in older adults, the relationship between anesthetic brain sensitivity (as measured by EEG) and preclinical/prodromal age-related changes in brain structure and function, and mechanisms by which the APOE4 allele leads to increased Alzheimer's Disease risk and neurocognitive decline. Together with collaborators, we use a transdisciplinary approach combining molecular/cellular assays (including ELISAs, proteomics, metabolomics, and flow cytometry) on pre- and post-operative CSF and plasma samples from older surgical surgical patients, functional and structural MRI neuroimaging, pre- and intra-operative EEG recordings, genetics (and epigenetics), and pre and postoperative delirium screening and cognitive testing. Overall, our hope is that the combination of these different methods will allow us to obtain insights into the mechanisms of perioperative neurocognitive disorders that could not be obtained by any single method alone.
Our group values mentorship, and we are happy to talk with prospective undergraduate, graduate or post-doctoral students with an interest in our work. -
Dominique Bergmann
Shirley R. and Leonard W. Ely, Jr. Professor of the School of Humanities and Sciences
Current Research and Scholarly InterestsWe use genetic, genomic and cell biological approaches to study cell fate acquisition, focusing on cases where cell fate is correlated with asymmetric cell division.
-
B. Bernheim
Edward Ames Edmonds Professor and Senior Fellow at the Stanford Institute for Economic Policy Research
BioB. Douglas Bernheim is the Edward Ames Edmonds Professor of Economics in the Department of Economics at Stanford University, as well as Department Chair. After completing an A.B. in Economics from Harvard University and a Ph.D. from the Massachusetts Institute of Technology, he joined the Stanford faculty as an Assistant Professor in 1982. He moved to Northwestern University’s J. L. Kellogg Graduate School of Management in 1988, and to Princeton University in 1990, before returning to Stanford in 1994. His awards and honors include election as a fellow of the American Academy of Arts and Sciences, election as a fellow of the Econometric Society, a John Simon Guggenheim Memorial Foundation Fellowship, and an Alfred P. Sloan Foundation Research Fellowship.
Professor Bernheim’s work has spanned a variety of fields, including public economics, behavioral economics, game theory, contract theory, industrial organization, political economy, and financial economics. His notable contributions include the following: in the area of game theory, introducing and exploring the concepts of rationalizability (thereby helping to launch the field of epistemic game theory), coalition-proofness, and collective dynamic consistency (also known as renegotiation-proofness); in the area of incentive theory, introducing and exploring the concepts of common agency and menu auctions, and developing a theory of incomplete contracts; in the area of industrial organization, developing theories of multimarket contact and exclusive dealing; concerning social motives in economics, introducing and exploring the concept of strategic bequest motives, and developing theories of conformity, Veblen effects, and the equal division norm; developing and applying a framework for behavioral welfare economics; developing an economic theory of addictive behaviors; conducting the earliest economic analyses of financial education; and analyzing the conceptual foundations for Ricardian equivalence.
Professor Bernheim is a Research Associate of the National Bureau of Economic Research, a Senior Fellow of the Stanford Institute for Economic Policy Research (SIEPR), and Co-Director of SIEPR's Tax and Budget Policy Program. He has also served as the Director of the Stanford Institute for Theoretical Economics (SITE), and as Co-Editor of the American Economic Review. He is currently serving as Co-Editor of the Handbook of Behavioral Economics. -
Daniel Bernstein
Alfred Woodley Salter and Mabel G. Salter Endowed Professor of Pediatrics
Current Research and Scholarly Interests1. Using iPSC-derived cardiomyocytes to understand hypertrophic cardiomyopathy and heart failure associated with congenital heart disease.
2. Role of alterations in mitochondrial dycamics and function in normal physiology and disease.
3. Differences between R and L ventricular responses to stress,
4. Immune biomarkers of risk after pediatric VAD implantation.
5. Biomarkers for post-transplant lymphoproliferative disorder. -
Jon Bernstein
Professor of Pediatrics (Genetics) and, by courtesy, of Genetics
Current Research and Scholarly InterestsMy research is focused on the diagnosis, discovery and delineation of rare genetic conditions with a focus on neurodevelopmental disorders. This work includes the application of novel computational methods and multi-omics profiling (whole genome sequencing, long-read DNA sequencing, RNA sequencing, methylomics, metabolomics). I additionally participate in an interdisciplinary project to develop induced pluripotent stem cell and assembloid models of genetic neurodevelopmental disorders.
-
Michael Bernstein
Professor of Computer Science and Senior Fellow at the Stanford Institute for Human-Centered AI
BioMichael Bernstein is a Professor of Computer Science at Stanford University, where he is a Bass University Fellow and Senior Fellow at the Stanford Institute for Human-Centered Artificial Intelligence. A nationally bestselling author, Michael focuses on designing social, societal, and interactive technologies. This research has been reported in venues such as The New York Times, TED AI, and MIT Technology Review, and Michael himself has been recognized with an Alfred P. Sloan Fellowship and the Computer History Museum's Tech for Humanity Prize. Michael holds a bachelor's degree in Symbolic Systems from Stanford University, as well as a master's degree and a Ph.D. in Computer Science from MIT.
-
Mark Francis Berry, MD
Mylavarapu Rogers Professor of Cardiothoracic Surgery
BioDr. Berry joined the Division of Thoracic Surgery at Stanford in August 2014. He came to Stanford from Duke University, where he had most recently served as Associate Professor. He received his medical degree at the University of Pennsylvania School of Medicine after receiving bachelors and masters degrees in Electrical Engineering at the University of Pennsylvania. He completed his residency in Cardiothoracic Surgery at Duke University Medical Center after performing a residency in General Surgery at the Hospital of the University of Pennsylvania. His Cardiothoracic Surgical training included a year dedicated to Minimally Invasive General Thoracic Surgery, a period that also included an American Association for Thoracic Surgery sponsored Traveling Fellowship at the University of Pittsburgh.
Dr. Berry practices all aspects of thoracic surgery, including procedures for benign and malignant conditions of the lung, esophagus, and mediastinum. He has a particular interest in minimally invasive techniques, and has extensive experience in treating thoracic surgical conditions using video-assisted thoracoscopic surgical (VATS), laparoscopic, robotic, endoscopic, and bronchoscopic approaches. He serves as the co-Director of the Stanford Minimally Invasive Thoracic Surgery Center (SMITS), and has both directed and taught in several minimally invasive thoracic surgery courses.
Dr. Berry also has a Masters of Health Sciences in Clinical Research from Duke University. His clinical research activities mirror his clinical interests and activities in optimizing short-term and long-term outcomes of patients with thoracic surgical conditions. He has more than 150 peer-reviewed publications, most of which are related to both the use of minimally invasive thoracic surgical techniques as well as evaluating outcomes after treatment of thoracic malignancies. His clinical practice and his research both focus on choosing the most appropriate treatment and approach for patients based on the individual characteristics of the patient and their disease process. -
Edward Bertaccini
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD), Emeritus
Current Research and Scholarly Interestsmolecular modeling of anesthetic-protein interactions, molecular modeling of the ligand-gated ion channels
-
Alice Bertaina MD, PhD
Lorry I. Lokey Professor
Current Research and Scholarly InterestsDr. Bertaina is a highly experienced clinician and will play a key role in supporting Section Chief Dr. Rajni Agarwal and Clinical Staff in the Stem Cell Transplant Unit at Lucile Packard Children’s Hospital. She will also continue her research on immune recovery and miRNA, understanding the mechanisms underlying immune reconstitution, Graft-versus-Host Disease (GvHD), and leukemia relapse after allogeneic HSCT in pediatric patients affected by hematological malignant and non-malignant disorders.
-
Carolyn Bertozzi
Baker Family Director of Sarafan ChEM-H, Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences and Professor, by courtesy, of Chemical and Systems Biology
BioCarolyn Bertozzi is the Baker Family Director of Sarafan ChEM-H, Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences and Professor, by courtesy, of Chemical and Systems Biology and of Radiology at Stanford University, and an Investigator of the Howard Hughes Medical Institute. She completed her undergraduate degree in Chemistry from Harvard University in 1988 and her Ph.D. in Chemistry from UC Berkeley in 1993. After completing postdoctoral work at UCSF in the field of cellular immunology, she joined the UC Berkeley faculty in 1996. In June 2015, she joined the faculty at Stanford University and became the co-director and Institute Scholar at Sarafan ChEM-H.
Prof. Bertozzi's research focuses on fundamental studies of disease-associated glycobiology and the development of new therapeutic modalities that target these pathways. Her inventions include bioorthogonal chemistries for in vivo imaging and bioconjugation, work for which she received the 2022 Nobel Prize in Chemistry. As well, her lab has developed next generation antibody-drug conjugates, lysosome-targeting chimeras (LYTACs), antibody-enzyme conjugates and antibody-lectin chimeras. Several of these new therapeutic modalities have been translated into clinical candidates for treatment of cancer and autoimmune diseases.
In addition to the Nobel Prize, Prof. Bertozzi has been recognized with many honors and awards for both her research and teaching accomplishments. For example, she is an elected member of the National Academy of Sciences, the National Academy of Medicine, the National Inventors Academy and the National Academy of Engineering, the American Academy of Arts and Sciences, the German Academy of Sciences Leopoldina, and she is a Foreign Fellow of the Royal Society. In addition, Prof. Bertozzi received the Priestley Medal of the American Chemical Society, the Welch Award, the Wolf Prize in Chemistry, the Heineken Prize, Lemelson-MIT award for inventors, and a MacArthur "Genius Award".
